Literature DB >> 34562569

Evaluating the optimal training paradigm for transcarotid artery revascularization based on worldwide experience.

Brajesh K Lal1, Richard Cambria2, Wesley Moore3, Minerva Mayorga-Carlin4, William Shutze5, Christopher L Stout6, Heath Broussard7, H Edward Garrett8, Wayne Nelson9, Jessica M Titus10, Sumaira Macdonald11, Rachel Lake4, John D Sorkin12.   

Abstract

BACKGROUND: Transcarotid artery revascularization (TCAR) is a new hybrid approach to carotid artery revascularization. Proctored training on live cases is an effort-, time-, and resource-intensive approach to learning new procedures. We analyzed the worldwide experience with TCAR to develop objective performance metrics for the procedure and compared the effectiveness of training physicians using cadavers or synthetic models to that of traditional in-person training on live cases.
METHODS: Physicians underwent one of three mandatory training programs: (1) in-person proctoring on live TCAR procedures, (2) supervised training on human cadavers, and (3) supervised training on synthetic models. The training details and information from all subsequent independently performed TCAR procedures were recorded. The composite clinical adverse events (ie, transient ischemic attack, stroke, myocardial infarction, death) and composite technical adverse events (ie, aborted procedure, conversion to surgery, bleeding, dissection, cranial nerve injury, or device failure, occurring within 24 hours were recorded). Four procedural proficiency measures were recorded: procedure time, flow-reversal time, fluoroscopy time, and contrast volume. We compared the adverse event rates between the procedures performed by physicians after undergoing the three training modes and tested whether the proficiency measures achieved during TCAR after training on cadavers and synthetic models were noninferior to proctored training.
RESULTS: From March 3, 2009 to May 7, 2020, 1160 physicians had undergone proctored (19.1%), cadaver-based (27.4%), and synthetic model-based (53.5%) TCAR training and had subsequently performed 17,283 TCAR procedures. The proctored physicians had treated younger patients and more patients with asymptomatic carotid stenosis and had had more prior experience with transfemoral carotid stenting. The overall 24-hour composite clinical and technical adverse event rates, adjusted for age, sex, and symptomatic status, were 1.0% (95% confidence interval, 0.8%-1.3%) and 6.0% (95% confidence interval, 5.4%-6.6%), respectively, and did not differ significantly by training mode. The proficiency measures of cadaver-trained and synthetic model-trained physicians were not inferior to those for the proctored physicians.
CONCLUSIONS: We have presented key objective proficiency metrics for performing TCAR and an analytic framework to assess adequate training for the procedure. Training on cadavers or synthetic models achieved clinical outcomes, technical outcomes, and proficiency measures for subsequently performed TCAR procedures similar to those achieved with training using traditional proctoring on live cases.
Copyright © 2021 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carotid; Credentialing; Stent; Training; Transcarotid artery revascularization

Mesh:

Year:  2021        PMID: 34562569      PMCID: PMC8792193          DOI: 10.1016/j.jvs.2021.08.085

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  16 in total

1.  Stenting versus endarterectomy for treatment of carotid-artery stenosis.

Authors:  Thomas G Brott; Robert W Hobson; George Howard; Gary S Roubin; Wayne M Clark; William Brooks; Ariane Mackey; Michael D Hill; Pierre P Leimgruber; Alice J Sheffet; Virginia J Howard; Wesley S Moore; Jenifer H Voeks; L Nelson Hopkins; Donald E Cutlip; David J Cohen; Jeffrey J Popma; Robert D Ferguson; Stanley N Cohen; Joseph L Blackshear; Frank L Silver; J P Mohr; Brajesh K Lal; James F Meschia
Journal:  N Engl J Med       Date:  2010-05-26       Impact factor: 91.245

2.  Resident Perspectives on Teaching During Awake Surgical Procedures.

Authors:  Claire S Smith; Robert Nolan; Kristina Guyton; Mark Siegler; Alexander Langerman; Nancy Schindler
Journal:  J Surg Educ       Date:  2019-05-03       Impact factor: 2.891

3.  Synthetic human tissue models can reduce the cost of device development.

Authors:  C Sakezles
Journal:  Med Device Technol       Date:  2009 Jan-Feb

4.  Age and outcomes after carotid stenting and endarterectomy: the carotid revascularization endarterectomy versus stenting trial.

Authors:  Jenifer H Voeks; George Howard; Gary S Roubin; Mahmoud B Malas; David J Cohen; W Charles Sternbergh; Herbert D Aronow; Mark K Eskandari; Alice J Sheffet; Brajesh K Lal; James F Meschia; Thomas G Brott
Journal:  Stroke       Date:  2011-10-06       Impact factor: 7.914

5.  Clinical competence statement of the Society for Vascular Surgery on training and credentialing for transcarotid artery revascularization.

Authors:  Brajesh K Lal; William Jordan; Vikram S Kashyap; Christopher J Kwolek; Wesley S Moore; Dipankar Mukherjee; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2020-06-20       Impact factor: 4.268

6.  Clinical need, design, and goals for the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis trial.

Authors:  Brajesh K Lal; James F Meschia; Thomas G Brott
Journal:  Semin Vasc Surg       Date:  2017-04-27       Impact factor: 1.000

7.  Carotid Stenting Versus Carotid Endarterectomy: What Did the Carotid Revascularization Endarterectomy Versus Stenting Trial Show and Where Do We Go From Here?

Authors:  Brajesh K Lal; James F Meschia; George Howard; Thomas G Brott
Journal:  Angiology       Date:  2016-08-09       Impact factor: 3.619

8.  Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study.

Authors: 
Journal:  JAMA       Date:  1995-05-10       Impact factor: 56.272

9.  Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators.

Authors:  H J Barnett; D W Taylor; M Eliasziw; A J Fox; G G Ferguson; R B Haynes; R N Rankin; G P Clagett; V C Hachinski; D L Sackett; K E Thorpe; H E Meldrum; J D Spence
Journal:  N Engl J Med       Date:  1998-11-12       Impact factor: 91.245

10.  Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal.

Authors:  Christopher J Kwolek; Michael R Jaff; J Ignacio Leal; L Nelson Hopkins; Rasesh M Shah; Todd M Hanover; Sumaira Macdonald; Richard P Cambria
Journal:  J Vasc Surg       Date:  2015-11       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.